EN
Corporate Governance コーポレート・ガバナンス

Corporate
Governance

Board of Directors

  • Kenji Nonaka

    M.D. , Ph.D.

  • Shinji Ogawa

    Ph.D.

  • Hiroyuki Ueno

    Ph.D.

  • Ichiro Kodama

  • Shogo Kato

  • Hideo Iwano

  • Akihiko Fujieda

Auditor

  • Tomoyoshi Matsuo

    Audit & Supervisory Board Member

  • Takashi Ohno

    CPA, CPTA

Member of Scientific Advisory Board

  • Shinya Yamanaka

    Director Emeritus of Center for iPS Cell Research and Application (“CiRA”), Kyoto University / Representative Director of the CiRA Foundation

  • Seigo Izumo

    Former Senior Vice President & Global Head, Regenerative Medicine Unit, Takeda Pharmaceutical Company Ltd. / Former Professor of Medicine, Harvard Medical School

  • Munehide Matsuhisa

    Director and Professor Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University

Member of Leadership Team

  • Kenji Nonaka

    President and CEO/CMO

  • Shinji Ogawa

    Vice president and CCO

  • Takanori Matsuo

    Head of Business Operations and COO

  • Yu Yoshimura

    Head of Finance and CFO

  • Tomoyuki Nishimoto

    Head of iPS cell-derived cardiomyocyte (iCM) Therapy Business Unit and CMTO

  • Ryo Ito

    Head of iPS cell-derived pancreatic islet cells (iPIC) Business Unit and CMTO

  • Kiyoko Nakatani

    Head of Quality Assurance and CQO

  • Takashi Yamamoto

    Head of Platform Business Unit

CEO: Chief Executive Officer, CCO: Chief Compliance Officer, COO: Chief Operating Officer, CMTO: Chief Manufacturing & Technology Officer,
CQO: Chief Quality Officer, CMO: Chief Medical Officer, CFO: Chief Financial Officer